person · Reporting owner
Leimkuhler William F.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGAN INCAGX · Entity 3828 | Director | June 10, 2026 | June 12, 2026 |
| Elite Health Systems Inc.EHSI · Entity 7531 | Director | August 06, 2025 | August 08, 2025 |
| Northern Power Systems Corp.NPS · Entity 164185 | Director | May 25, 2017 | May 30, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGAN INC
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,028 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Exercise / conversion · Acquired 533 · Balance 37,028 F1: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. |
| Time-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 834 |
Reported balance
After 2026-06-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-10 · Exercise / conversion · Disposed 530 · Balance 834 F1: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. |
| Time-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,023 |
Reported balance
After 2026-06-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-06-10 · Grant · Acquired 189 · Balance 1,023 F2: On June 10, 2026 the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first. |
| Common StockSEC Table I · non-derivative | IndirectSelf as Trustee for Elizabeth K Leimkuhler Trust | 500 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 500 |
| Common StockSEC Table I · non-derivative | IndirectSelf as Trustee for Emily K Leimkuhler Trust | 500 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 500 |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends.
F2: On June 10, 2026 the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first.
Elite Health Systems Inc.
Report date August 06, 2025 · Filed August 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 265,000 |
Reported balance
After 2025-08-06 transaction · row 1
1 source rowRow 1 · 2025-08-06 · Grant · Acquired 40,000 · Balance 265,000 |
| 2025 Equity Incentive PlanSEC Table II · derivative / convertible security · Conversion / exercise price $0.95 · Expires 2035-08-06 | Direct | 25,000 |
Reported balance
After 2025-08-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-08-06 · Grant · Acquired 25,000 · Balance 25,000 F1: NA |
Filing footnotes · ownership attribution and instrument terms
F1: NA
Northern Power Systems Corp.
Report date May 25, 2017 · Filed May 30, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 148,441 |
Reported balance
After 2017-05-25 transaction · row 1
1 source rowRow 1 · 2017-05-25 · Grant · Acquired 30,000 · Balance 148,441 F1: Each restricted stock unit represents a contingent right to receive one share of NPS common stock. The grant represents an annual grant of restricted stock units to non-executive directors under the Northern Power Systems Corp. 2014 Stock Option and Incentive Plan. 25% of the shares vest upon grant and the remaining 75% vest in equal installments over the subsequent 3 quarters. |
| Common SharesSEC Table I · non-derivative | IndirectBy Simplified Employee Pension IRA | 10,000 |
Reported balance
Holding disclosure · report date 2017-05-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of NPS common stock. The grant represents an annual grant of restricted stock units to non-executive directors under the Northern Power Systems Corp. 2014 Stock Option and Incentive Plan. 25% of the shares vest upon grant and the remaining 75% vest in equal installments over the subsequent 3 quarters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 189 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001361943-26-000012 · form4-06122026_040609.xml · derivative · entry 5 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,023 Underlying: Common Stock · 189 shares Expires not disclosed F2 · derivative.exercise_date: On June 10, 2026 the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first. F2 · derivative.expiration_date: On June 10, 2026 the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 530 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001361943-26-000012 · form4-06122026_040609.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 834 Underlying: Common Stock · 530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 533 | $0.00 | $0.00 |
DisclosureSEC source: 0001361943-26-000012 · form4-06122026_040609.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 400 | $618.61 | $247,444.00 |
DisclosureSEC source: 0001361943-26-000010 · form4-04292026_050403.xml · nonDerivative · entry 3 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Self as Trustee for Elizabeth K Leimkuhler Trust Disclosed balance after: 500 F3 · shares: On April 28, 2026, the Elizabeth K. Leimkuhler Trust, of which the Reporting Person serves as Trustee, sold 400 shares of the Issuer's common stock in an open market transaction. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 400 | $621.14 | $248,456.00 |
DisclosureSEC source: 0001361943-26-000010 · form4-04292026_050403.xml · nonDerivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Self as Trustee for Emily K Leimkuhler Trust Disclosed balance after: 500 F2 · shares: On April 28, 2026, the Emily K. Leimkuhler Trust, of which the Reporting Person serves as Trustee, sold 400 shares of the Issuer's common stock in an open market transaction. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 5,000 | $617.41 | $3,087,050.00 |
DisclosureSEC source: 0001361943-26-000010 · form4-04292026_050403.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,495 F1 · shares: On April 28, 2026 the Reporting Person sold 5,000 shares of the Issuer's common stock on the open market at an average price of $617.41 per share. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 11:38 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 8,444 | $598.49 | $5,053,649.56 |
DisclosureSEC source: 0001361943-26-000008 · form4-04152026_110453.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,495 F1 · shares: On April 13, 2026, the Reporting Person sold 8,444 shares of the Issuer's common stock on the open market at an average price of $598.49 per share. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 11,044 | $379.15 | $4,187,332.60 |
DisclosureSEC source: 0001361943-26-000006 · form4-01212026_050101.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,939 F1 · shares: On January 16, 2026, the Reporting Person sold 11,044 shares of the Issuer's common stock at an average price of of $379.15 per share. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 4,212 | $320.53 | $1,350,072.36 |
DisclosureSEC source: 0001361943-26-000004 · form4-01142026_050101.xml · nonDerivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,983 F2 · shares: On January 13, 2026, the Reporting Person sold 4,212 shares of the Issuer's common stock on the open market at an average price of $320.53 per share. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,164 | $318.28 | $688,757.92 |
DisclosureSEC source: 0001361943-26-000004 · form4-01142026_050101.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,195 F1 · shares: On January 12, 2026, the Reporting Person sold 2,164 shares of the Issuer's common stock on the open market at an average price of $318.28 per share. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $35.72 Strike: $35.72 | $178,600.00 |
DisclosureSEC source: 0001361943-26-000002 · form4-01092026_050101.xml · derivative · entry 8 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 5,000 shares Expires 2032-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $37.13 Strike: $37.13 | $185,650.00 |
DisclosureSEC source: 0001361943-26-000002 · form4-01092026_050101.xml · derivative · entry 7 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 5,000 shares Expires 2031-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $45.75 Strike: $45.75 | $457,500.00 |
DisclosureSEC source: 0001361943-26-000002 · form4-01092026_050101.xml · derivative · entry 6 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,500 Underlying: Common Stock · 10,000 shares Expires 2030-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $40.15 Strike: $40.15 | $401,500.00 |
DisclosureSEC source: 0001361943-26-000002 · form4-01092026_050101.xml · derivative · entry 5 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 10,000 shares Expires 2029-12-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 4,463 | $35.72 | $159,418.36 |
DisclosureSEC source: 0001361943-26-000002 · form4-01092026_050101.xml · nonDerivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 4,442 | $37.13 | $164,931.46 |
DisclosureSEC source: 0001361943-26-000002 · form4-01092026_050101.xml · nonDerivative · entry 3 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,626 | $45.75 | $394,639.50 |
DisclosureSEC source: 0001361943-26-000002 · form4-01092026_050101.xml · nonDerivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,794 | $40.15 | $353,079.10 |
DisclosureSEC source: 0001361943-26-000002 · form4-01092026_050101.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 7, 2026, the Reporting Person exercised his stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method. Read SEC document |
| December 23, 2025 Filed Dec 29, 2025 22:00 UTC | ARGAN INC AGX · Entity 3828 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001361943-25-000007 · form4-12292025_051203.xml · nonDerivative · entry 3 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,034 F3 · shares: On December 23, 2025, the Reporting Person made a bona fide gift of 500 shares of the Issuer's common stock. Read SEC document |
| December 23, 2025 Filed Dec 29, 2025 22:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 100 | $337.93 | $33,793.00 |
DisclosureSEC source: 0001361943-25-000007 · form4-12292025_051203.xml · nonDerivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Self as Trustee for Elizabeth K Leimkuhler Trust Disclosed balance after: 900 F2 · shares: On December 23, 2025, the Elizabeth K. Leimkuhler Trust, of which the Reporting Person serves as Trustee, sold 100 shares of the Issuer's common stock at a price of $337.93 per share in an open market transaction. Read SEC document |
| December 23, 2025 Filed Dec 29, 2025 22:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 100 | $337.01 | $33,701.00 |
DisclosureSEC source: 0001361943-25-000007 · form4-12292025_051203.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Self as Trustee for Emily K Leimkuhler Trust Disclosed balance after: 900 F1 · shares: On December 23, 2025, the Emily K. Leimkuhler Trust, of which the Reporting Person serves as Trustee, sold 100 shares of the Issuer's common stock at a price of $337.01 per share in an open market transaction. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 22:44 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001361943-25-000005 · form4-12172025_101253.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,364 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 22:44 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001361943-25-000005 · form4-12172025_101253.xml · nonDerivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends. Read SEC document |
| December 14, 2025 Filed Dec 17, 2025 22:44 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001361943-25-000005 · form4-12172025_101253.xml · derivative · entry 3 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,114 Underlying: Common Stock · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends. Read SEC document |
| December 14, 2025 Filed Dec 17, 2025 22:44 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 856 | $0.00 | $0.00 |
DisclosureSEC source: 0001361943-25-000005 · form4-12172025_101253.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends. Read SEC document |
| October 01, 2025 Filed Oct 1, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 11,802 | $274.73 | $3,242,363.46 |
DisclosureSEC source: 0001361943-25-000003 · form4-10012025_041012.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,834 F1 · shares: On October 1, 2025, the Reporting Person sold 11,806 shares of the Issuer's common stock on the open market at an average price of $274.73 per share. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:50 UTC | Elite Health Systems Inc. EHSI · Entity 7531 | Grant2025 Equity Incentive Plan · Derivative | 25,000 | Not disclosed Strike: $0.95 | Not disclosed |
DisclosureSEC source: 0001437749-25-025754 · rdgdoc.xml · derivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: common stock · 25,000 shares Expires 2035-08-06 F1 · price: NA Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:50 UTC | Elite Health Systems Inc. EHSI · Entity 7531 | GrantCommon Stock | 40,000 | $0.95 | $38,000.00 |
DisclosureSEC source: 0001437749-25-025754 · rdgdoc.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,000 Read SEC document |
| June 30, 2025 Filed Jun 30, 2025 22:39 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 7,604 | $222.03 | $1,688,316.12 |
DisclosureSEC source: 0001415889-25-018557 · form4-06302025_100630.xml · nonDerivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,636 F2 · shares: On June 30, 2025, the Reporting Person sold 7,604 shares of the Issuer's common stock on the open market at an average price of $222.03 per share. Read SEC document |
| June 27, 2025 Filed Jun 30, 2025 22:39 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 4,051 | $221.25 | $896,283.75 |
DisclosureSEC source: 0001415889-25-018557 · form4-06302025_100630.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,240 F1 · shares: On June 27, 2025, the Reporting Person sold 4,051 shares of the Issuer's common stock on the open market at an average price of $221.25 per share. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 23:54 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 530 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017906 · form4-06202025_110611.xml · derivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,947 Underlying: Common Stock · 530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On June 17, 2025, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 530 shares of the Issuer's common stock. The TRSUs will vest fully on April 17, 2026. F1 · derivative.expiration_date: On June 17, 2025, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 530 shares of the Issuer's common stock. The TRSUs will vest fully on April 17, 2026. Read SEC document |
| June 11, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 8,345 | $219.31 | $1,830,141.95 |
DisclosureSEC source: 0001415889-25-016655 · form4-06112025_040601.xml · nonDerivative · entry 5 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,291 F5 · shares: On June 11, 2025, the Reporting Person sold 8,345 shares of the Issuer's common stock at an average price of $219.31 per share. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 388 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-016655 · form4-06112025_040601.xml · derivative · entry 11 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,417 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends F4 · derivative.expiration_date: Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-016655 · form4-06112025_040601.xml · nonDerivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $41.19 Strike: $41.19 | $411,900.00 |
DisclosureSEC source: 0001415889-25-016655 · form4-06112025_040601.xml · derivative · entry 10 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 10,000 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On June 9, 2025, the Reporting Person exercised his stock option awarded on December 12, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $41.19 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $46.35 Strike: $46.35 | $463,500.00 |
DisclosureSEC source: 0001415889-25-016655 · form4-06112025_040601.xml · derivative · entry 9 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,500 Underlying: Common Stock · 10,000 shares Expires 2028-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 9, 2025, the Reporting Person exercised his stock option awarded on January 11, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $46.35 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $71.75 Strike: $71.75 | $717,500.00 |
DisclosureSEC source: 0001415889-25-016655 · form4-06112025_040601.xml · derivative · entry 8 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,500 Underlying: Common Stock · 10,000 shares Expires 2027-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 9, 2025, the Reporting Person exercised his stock option awarded on January 5, 2017 to purchase 10,000 shares of the Issuer's common stock at a price of $71.75 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,308 | $41.19 | $342,206.52 |
DisclosureSEC source: 0001415889-25-016655 · form4-06112025_040601.xml · nonDerivative · entry 3 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On June 9, 2025, the Reporting Person exercised his stock option awarded on December 12, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $41.19 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,096 | $46.35 | $375,249.60 |
DisclosureSEC source: 0001415889-25-016655 · form4-06112025_040601.xml · nonDerivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 9, 2025, the Reporting Person exercised his stock option awarded on January 11, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $46.35 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 7,053 | $71.75 | $506,052.75 |
DisclosureSEC source: 0001415889-25-016655 · form4-06112025_040601.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 9, 2025, the Reporting Person exercised his stock option awarded on January 5, 2017 to purchase 10,000 shares of the Issuer's common stock at a price of $71.75 per share, using the net settle method. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $30.44 Strike: $30.44 | $304,400.00 |
DisclosureSEC source: 0001415889-25-001851 · form4-01222025_040104.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,500 Underlying: Common Stock · 10,000 shares Expires 2026-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 21, 2025, the Reporting Person exercised his stock option awarded on January 7, 2016 to purchase 10,000 shares of the Issuer's common stock at a price of $30.44 per share, using the net settle method. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,345 | $30.44 | $254,021.80 |
DisclosureSEC source: 0001415889-25-001851 · form4-01222025_040104.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 21, 2025, the Reporting Person exercised his stock option awarded on January 7, 2016 to purchase 10,000 shares of the Issuer's common stock at a price of $30.44 per share, using the net settle method. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 22:44 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029503 · form4-12162024_101231.xml · derivative · entry 7 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,805 Underlying: Common Stock · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 22:44 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029503 · form4-12162024_101231.xml · derivative · entry 6 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,638 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 22:44 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 835 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029503 · form4-12162024_101231.xml · nonDerivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 22:44 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029503 · form4-12162024_101231.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:44 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 388 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029503 · form4-12162024_101231.xml · derivative · entry 5 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,388 Underlying: Common Stock · 388 shares Expires not disclosed F3 · derivative.exercise_date: On December 12, 2024, the Reporting Person was granted TRSUs covering 388 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2025. F3 · derivative.expiration_date: On December 12, 2024, the Reporting Person was granted TRSUs covering 388 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2025. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 21:37 UTC | Elite Health Systems Inc. USNU · Entity 7531 | GrantCommon Stock | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-036469 · rdgdoc.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 F1 · price: Effective November 29, 2024, the Issuer granted to the Reporting Person 75,000 shares of the Issuer's Common Stock, fully vested as of the date of grant, for past and future service to the issuer. Read SEC document |
| September 23, 2024 Filed Sep 23, 2024 20:03 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 10,000 | $96.20 | $962,000.00 |
DisclosureSEC source: 0001361943-24-000004 · primary_doc.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,852 F1 · shares: On September 23, 2024, the Reporting Person sold 10,000 shares of the Issuer's common stock on the open market at an average price of $96.20 per share. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 13:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $31.82 | $0.00 |
DisclosureSEC source: 0001415889-24-017317 · form4-06182024_090602.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,500 Underlying: Common Stock · 10,000 shares Expires 2024-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 14, 2024, the Reporting Person exercised his option awarded on December 11, 2014 to purchase 10,000 shares of the Issuer's common stock at a price of $31.82 per share, using the net settle approach. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.